Biopharma[email protected] | 91-98207-90795 | v-Card
Hetal Vora is a Director in Stifel’s Global Healthcare Group with over fifteen years in M&A, business finance, investment banking, and credit risk. She joined Stifel in 2023 through the Torreya acquisition.
Hetal joined Torreya in 2018 after 5 years within the M&A function of Hindustan Unilever Ltd, one of India’s largest FMCG companies. Prior to that, Hetal worked in diverse credit and equity analyst roles with organizations such as UBS, Edelweiss Capital, and Principal Mutual fund, amongst others.
Hetal is a trustee member of VYF, a non-profit organization which works with under privileged children. Hetal earned her B.com in commerce from Narsee Monjee College of Commerce & Economics, Mumbai University. She is also a member of the Association of Chartered Financial Accountants (UK). Hetal is fluent in English and Hindi.